Stock Quote (NASDAQ: ASMB)
Price:
7.33
Change:
+ 0.07
Day High:
7.66
Day Low:
7.27
Volume:
13,600
12:12 PM ET on Sep 2, 2014
Delayed at least 20min., by eSignal.
Investor Relations

SHAREHOLDER TOOLS
Briefcase Printed Materials Email Alerts
Download Center snapshot RSS Mobile Investor

PROXY STATEMENT
2014 Proxy Statement
ANNUAL REPORT
2013 Annual Report
Stock price graph
     

Assembly Biosciences (Nasdaq: ASMB) is a biopharmaceutical company developing innovative treatments for hepatitis B virus infection (HBV) and C. difficile-associated diarrhea (CDAD). Both programs have breakthrough potential to provide higher cure rates for these debilitating diseases.

View all »   RSSRecent Releases

Jul 14, 2014
Ventrus Biosciences Becomes Assembly Biosciences as Stockholders Approve Merger With Assembly Pharmaceuticals, Inc.

Jun 9, 2014
Ventrus Biosciences Files and Commences Mailing of Definitive Proxy Materials for July 10th Annual Meeting

 
Home About Ventrus Product Pipeline Contact Investor Relations